ROSE
Start date:Historic End date:
Jan 2009 Co-ordinated by:
NHS Lothian
Risk Stratification Of Syncope in the Emergency department
Aim
To develop and validate a Clinical Decision Rule using history, examination, electrocardiographic and biochemical markers, to predict one month outcome for patients presenting with syncope to the Emergency Department
Trial Design
Single-centre, prospective, observational cohort study, conducted in the Emergency Department (ED) of the Royal Infirmary of Edinburgh.
List of Publications – references
- Reed MJ, Newby DE, Coull AJ, Jacques KG, Prescott RJ, Gray AJ. Risk stratification Of Syncope in the Emergency department: The ROSE study. JACC 2010: 55(8); 713-721. PMID: 20170806
- Reed MJ, Mills NL, Weir CJ. Sensitive troponin assay predicts outcome in syncope. Emerg Med J. 2012; 29(12): 1001-3. PMID: 22962048
- Reed MJ, Henderson SS, Newby DE, Gray AJ. One-year prognosis after syncope and the failure of the ROSE decision instrument to predict 1 year adverse events. Annals of Emergency Medicine 2011; DOI: 10.1016/j.annemergmed.2010.12.021. PMID: 21288597
- Sun BC, Costantino G, Barbic F, Bossi I, Casazza G, Dipaola F, McDermott F, Quinn J, Reed MJ, Sheldon RS, Solbiati M, Thiruganasambandamoorthy V, Krahn AD, Beach D, Bodemer N, Brignole M, Casagranda I, Duca P, Falavigna G, Ippoliti R, Montano N, Olshansky B, Raj SR, Ruwald MH, Shen W-K, Stiell I, Ungar A, van Dijk JG, van Dijk N, Wieling W, Furlan R. Priorities for Emergency Department Syncope Research. Published ahead of print Annals of Emergency Medicine May 29, 2014. DOI: http://dx.doi.org/10.1016/j.annemergmed.2014.04.014. PMID: 24882667
- Sun BC, Thiruganasambandamoorthy V, Dela Cruz J, Abe H, Barbic F, Blanc J-J, Colivicchi F, Dipaola F, Furlan R,Costantino G, Grossman S, Hess E, Krahn A, Lipsitz L, Morillo C, Olshansky B, Quinn J, Raviele A, Reed MJ, Sarasin F, Satish R, Serrano L, Sheldon R, Thijs R, Ungar A, van Dijk G, van Dijk N. Standardized Reporting Guidelines for Emergency Department Syncope Risk Stratification Research. Accepted by Academic Emergency Medicine.
Chief Investigator
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Local PI
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
More EMERGE Trials
ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study
ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)
Assisting in identifying patients with Humeral shaft fractures in the ED by screening.
Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.
HU-FIX Trial
People who develop an Acute Kidney Injury (AKI) often have a poor prognosis and many go on to develop chronic kidney disease (CKD). The recognition that AKI and CKD are linked is recent and the molecular pathways that control the transition from acute injury to chronic disease are not well defined. Currently there are no specific treatments that reduce the risk of progressing to CKD after AKI.
Preliminary investigations (not yet published) suggest that AKI causes sustained activation of the endothelin (ET) system to the long-term detriment of renal and systemic haemodynamic function. These pilot data form the basis of our project that seeks to determine whether the ET system is active in patients with AKI and, thus, represents a potential target for therapeutic intervention.
KRAKIL aims to recruit altogether 100 patients from across the emergency department, acute medical unit and inpatient wards at the Royal Infirmary. 50 of which with AKI’s and 50 matched controls with normal kidney function. We will monitor their bloods and urine for 90 days and compare the data from between the two groups.